- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02377063
The Effect of Fruit/Vegetable Drinks on the Human Intestine
Study of the Effect of Fruit/Vegetable Based Supplementation on Microbiome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A total of 20 subjects will be recruited from The UCLA Center for Human Nutrition/Clinical Trials Unit database, print and/or radio advertisements, UCLA campus wide e-mail, the clinicaltrials.gov website, and flyers posted on campus and in the community.
Interested persons will call a telephone number dedicated to the study where they will be instructed to leave their name and phone number. These individuals will be contacted by a study staff member, who will briefly describe the study and answer any questions to ascertain interest. If the individual is interested they will be asked to complete a brief pre-screen form over the telephone to establish eligibility. Individuals who remain interested will be invited for a screening visit. Pre-screen surveys for those not eligible will be shredded.
At screening, informed consent and HIPAA authorization will be reviewed and signed prior to any procedures being done, a medical history will be obtained. If subjects are healthy by medical history the following procedures will be conducted:
- a fasting blood sample will be collected for routine safety labs (CBC and Chemistry Panel)
- complete medical and medication history
- brief physical examination (including vital signs, height and weight)
- Dietary instruction to limit consumption of <3 servings of fruit and vegetables, vitamins and antibiotics
- Dispense materials to collect fecal sample
Results will be reviewed by the study physician for compliance to inclusion and exclusion criteria and the subject will be collected and instructed whether or not they are eligible and should proceed with the stool collection after 2 weeks of dietary compliance. Once the collection is obtained subjects will be asked to return to the clinic in 24 hours.
Baseline, days 4 and 17
During the study visits, the following assessments will be conducted:
- Vital signs, body weight
- Collect fecal sample
- Fasting blood sample
- 24 hour urine
- Dispense materials to collect fecal sample
- Dispense study supplement (Baseline and Day 17 only)
- Assess for compliance of study supplement
- Instructions on symptom diary
- General well-being questionnaire
- Subjects who are compliant will be given a 3-day supply of fruit/vegetable juice at the end of the study
Subjects will be instructed to start with their first juice upon waking or when the normally eat breakfast at intervals of approximately two hours throughout the day. Five (5) 16oz. juices and one (1) 16oz almond milk drink will be numbered and subjects will be asked to consume the product in the numbered sequence. Subjects will be instructed to avoid alcohol, caffeine, and nicotine and hydrate by drinking 8 glasses of water per day for the duration of the study. If needed, subjects will be allowed to drink a cup of herbal tea, water with lemon, almonds, cucumber or an apple during the fruit/juice supplementation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90095
- UCLA Center for Human Nutrition
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18-50 years of age at screen
- Subjects must read and sign the Institutional Review Board-approved written informed consent prior to the initiation of any study specific procedures or enrollment. A subject will be excluded for any condition that might compromise the ability to give truly informed consent.
Exclusion Criteria:
- Any subject with a history of diabetes mellitus on medications, hyperlipidemia on medications, or other serious medical condition, such as chronic hepatic or renal disease, bleeding disorder, congestive heart disease, chronic diarrhea disorders, myocardial infarction, coronary artery bypass graft, angioplasty within 6 months prior to screening, current diagnosis of uncontrolled hypertension (defined as systolic BP>160mmHg, diastolic BP>95mmHg), active or chronic gastrointestinal disorders, bulimia, anorexia, or endocrine diseases (except thyroid disease requiring medication) as indicated by medical history or routine physical examination.
- Any subject with a screening laboratory value outside of the laboratory normal range that is considered clinically significant for study participation by the investigator.
- Any subject who currently uses tobacco products.
- Any history of gastrointestinal disease except for appendectomy
- No antibiotics or laxatives use during the 2 months before the study.
- Any allergies to nuts
- Any subject who is unable or unwilling to comply with the study protocol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: pressed juice 6 bottles
Subjects will consume pressed juice daily for 3 days.
|
Subjects will be taking vegetable/fruit juice supplementation for 3 days.
Blood, urine and stool samples will be collected at baseline, day 4 and day 17.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Colonic Flora Composition
Time Frame: baseline and day 4
|
Changes in microbial count (%) were calculated as the values at day 4 minus the values at baseline
|
baseline and day 4
|
Collaborators and Investigators
Investigators
- Principal Investigator: Zhaoping Li, M.D., Ph.D., UCLA Department of Medicine, Division of Clinical Nutrition
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-000274
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intestinal Bacteria Flora Disturbance
-
Da VolterraCompletedIntestinal Bacteria Flora DisturbanceFrance
-
TCI Co., Ltd.RecruitingIntestinal Bacteria Flora DisturbanceTaiwan
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedIntestinal Bacteria Flora Disturbance | Feeding; Disorder, Nonorganic Origin | Calcium DisorderTurkey
-
DOMCA S.A.CompletedIntestinal Bacteria Flora DisturbanceSpain
-
Farmoquimica S.A.CompletedConstipation | Intestinal Bacteria Flora Disturbance
-
The First Affiliated Hospital of Nanchang UniversityCompletedAcute Pancreatitis | Intestinal Bacteria Flora Disturbance | Fecal Microbiota Transplantation | Intestinal DysfunctionChina
-
First Affiliated Hospital of Chengdu Medical CollegeUnknownAcute Pancreatitis | Intestinal Bacteria Flora Disturbance | Fecal Microbiota Transplantation | Intestinal DysfunctionChina
-
National Cheng-Kung University HospitalNational Science Council, TaiwanUnknownGastrointestinal Function | Intestinal Bacteria FloraTaiwan
-
Nanjing First Hospital, Nanjing Medical UniversityNot yet recruitingInfections | Helicobacter Pylori Infection | Intestinal Bacteria Flora DisturbanceChina
-
Academisch Medisch Centrum - Universiteit van Amsterdam...University of Padova; Centers for Disease Control and Prevention; Aga Khan University and other collaboratorsCompletedRotavirus Infections | Reaction - Vaccine Nos | Intestinal Bacteria Flora Disturbance
Clinical Trials on Pressed Juice
-
TCI Co., Ltd.CompletedCardiovascular DiseasesChina
-
TCI Co., Ltd.Completed
-
Kanta-Häme Central HospitalLinnan Klinikka Oy; Finnish Red Cross Blood Service; MTT Agrifood Research FinlandCompleted
-
San Diego State UniversityRecruiting
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedFeeding Behavior | Inhibition (Psychology)
-
Universidad Francisco de VitoriaUniversity of Alcala; University of SevilleCompleted
-
University of Colorado, DenverCompletedProstate CancerUnited States
-
Karolinska InstitutetRecruiting
-
Northumbria UniversityCompletedCognitive Impairment | Cerebrovascular CirculationUnited Kingdom
-
Bangor UniversityCompleted